A Trial to Evaluate the Efficacy of Poziotinib, Pan HER Inhibitor in Recurrent/Metastatic Esophageal Cancer (R/M ESCC)

NCT03770988 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Inoperable or Recurrent or Metastatic Esophageal Squamous Carcinoma

Interventions

DRUG: Treatment with Poziotinib

Sponsor

Yonsei University